MDxHealth SA (MDXH) - Financial and Strategic SWOT Analysis Review

November 2021 | 55 pages | ID: M2FA723EA2FEN
GlobalData

Abstracts

MDxHealth SA (MDXH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment, and the personalized treatment of patients. The company’s products portfolio includes ConfirmMDx, a epigenetic assay that detects epigenetic effect of cancer; SelectMDx, a liquid biopsy assay for prostate cancer. MdxHealth tests are based on MSP (Methylation-Specific polymerase chain reaction) technology, a proprietary DNA-based platform. It also offers the biomarker development services to many pharmaceutical companies. MDxHealth markets its products through sales forces, partnerships and distributors. The company has operations in, the Netherlands, Belgium, and the US. MDxHealth is headquartered in Herstal, Liege, Belgium.

MDxHealth SA Key Recent Developments

Aug 26,2021: MDxHealth Reports Half Year 2021 Results
May 27,2021: MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings
Jan 21,2021: MDxHealth launches capital increase and provides preliminary 2020 financial results
Oct 21,2020: MDxHealth provides Q3-2020 business update
Aug 26,2020: MDxHealth reports half year 2020 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

MDxHealth SA - Key Facts
MDxHealth SA - Key Employees
MDxHealth SA - Key Employee Biographies
MDxHealth SA - Major Products and Services
MDxHealth SA - History
MDxHealth SA - Company Statement
MDxHealth SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
MDxHealth SA - Business Description
Business Segment: Government Grants
Performance
Business Segment: License Revenue
Performance
Business Segment: Royalties
Performance
Business Segment: Service Revenue
Performance
Geographical Segment: Belgium
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Poland
Performance
Geographical Segment: Rest of EU
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: Spain
Performance
Geographical Segment: The Netherlands
Performance
Geographical Segment: The US
Performance
MDxHealth SA - SWOT Analysis
SWOT Analysis - Overview
MDxHealth SA - Strengths
MDxHealth SA - Weaknesses
MDxHealth SA - Opportunities
MDxHealth SA - Threats
MDxHealth SA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

MDxHealth SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
MDxHealth SA, Medical Equipment, Deals By Type, 2015 to YTD 2021
MDxHealth SA, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 26, 2021: MDxHealth Reports Half Year 2021 Results
May 27, 2021: MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings
Jan 21, 2021: MDxHealth launches capital increase and provides preliminary 2020 financial results
Oct 21, 2020: MDxHealth provides Q3-2020 business update
Aug 26, 2020: MDxHealth reports half year 2020 results
Apr 20, 2020: MDxHealth to receive $2.3 million “Paycheck Protection Program” loan under the U.S. CARES Act
Apr 09, 2020: MDxHealth provides Q1-2020 business update
Feb 26, 2020: MDxHealth reports financial year 2019 results and provides outlook for 2020
Feb 26, 2020: MDxHealth reports financial year 2020 results and provides outlook for 2021

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

MDxHealth SA, Key Facts
MDxHealth SA, Key Employees
MDxHealth SA, Key Employee Biographies
MDxHealth SA, Major Products and Services
MDxHealth SA, History
MDxHealth SA, Subsidiaries
MDxHealth SA, Key Competitors
MDxHealth SA, Ratios based on current share price
MDxHealth SA, Annual Ratios
MDxHealth SA, Annual Ratios (Cont...1)
MDxHealth SA, Interim Ratios
MDxHealth SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
MDxHealth SA, Medical Equipment, Deals By Type, 2015 to YTD 2021
MDxHealth SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

MDxHealth SA, Performance Chart (2016 - 2020)
MDxHealth SA, Ratio Charts
MDxHealth SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
MDxHealth SA, Medical Equipment, Deals by Type, 2015 to YTD 2021